financetom
Business
financetom
/
Business
/
Petrobras sees vet center key to Equatorial Margin plans ready by March, sources say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Petrobras sees vet center key to Equatorial Margin plans ready by March, sources say
Feb 17, 2025 1:41 PM

ANGRA DOS REIS, Brazil, Feb 17 (Reuters) - Brazilian oil

firm Petrobras expects to ready a veterinary center in the

Amazon to care for animals in the event of an oil spill by the

end of March, two sources told Reuters on Monday.

The animal care center in the northern state of Amapa is one

of the main demands from Brazil's environmental agency Ibama

still not met by Petrobras in order to potentially

get approval to drill in an offshore area near the Amazon River.

Ibama blocked Petrobras from drilling the well in the

environmentally sensitive region in 2023, but the company filed

a new request, which the agency is currently assessing, with no

deadline to give a final answer.

Brazilian President Luiz Inacio Lula da Silva has defended

Petrobras' bid to explore the region. He said last week, "Ibama

is a government agency that seems to be against the government."

Petrobras CEO Magda Chambriard said on Monday that if

Ibama grants the license for the exploratory campaign at the

mouth of the Amazon, the company will do everything "extremely

safely" and will have the "best emergency apparatus in the

world."

The works to build the veterinary center are in their final

stages, the sources said, but added that they have faced a delay

due to rains in the region. Initially, they said, Petrobras was

expecting to finish the center in February.

The so-called Equatorial Margin is Brazil's most promising

oil frontier, sharing geology with nearby Guyana, where Exxon

Mobil ( XOM ) is developing huge fields.

While the region holds great potential for Petrobras, the

firm has faced stiff resistance from local Indigenous

communities and federal prosecutors related to its bid to drill

there

Reuters reported last October, citing documents, that the

head of Ibama, Rodrigo Agostinho, asked Petrobras for further

details concerning the request, even after experts at the agency

advocated that the request be dismissed.

Petrobras director of exploration and production Sylvia dos

Anjos said last month that she expects the firm to receive

approval from Ibama in the first quarter of this year.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved